The influence of organisational management on door-to-needle times for fibrinolytic treatment M. Vicente-Pascual; A. Quilez; M.P. Gil; C. González-Mingot; D. Vázquez-Justes; G. Mauri-Capdevila; J. Sanahuja; C. García-Vázquez; F. Purroy;

A novel Notch 3 mutation (pathogenic variant c.1565G>C) in CADASIL C.A. Rodriguez; O.J.H. Fustes; C.B.T. Arteaga;